BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2355439)

  • 21. Clinical inquiries. Should liver enzymes be checked in a patient taking niacin?
    Rizakallah GS; Mertens MK; Brown ML; Sanner L
    J Fam Pract; 2005 Mar; 54(3):265-8. PubMed ID: 15755381
    [No Abstract]   [Full Text] [Related]  

  • 22. Niacin revisited: clinical observations on an important but underutilized drug.
    Henkin Y; Oberman A; Hurst DC; Segrest JP
    Am J Med; 1991 Sep; 91(3):239-46. PubMed ID: 1892143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rediscovery of crystalline niacin.
    Palumbo PJ
    Mayo Clin Proc; 1991 Jan; 66(1):112-3. PubMed ID: 1988752
    [No Abstract]   [Full Text] [Related]  

  • 24. All niacin is not the same.
    Frost PH
    Ann Intern Med; 1991 Jun; 114(12):1065. PubMed ID: 2029108
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute liver failure and encephalopathy in a 15-month-old infant.
    Agran PF; Zenk KE; Romansky SG
    Am J Dis Child; 1983 Nov; 137(11):1107-14. PubMed ID: 6637917
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and side effects of sustained-release niacin.
    Shields M; Beckmann SL
    JAMA; 1994 Aug; 272(7):514; author reply 514-5. PubMed ID: 8046797
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and side effects of sustained-release niacin.
    Keenan JM; Ripsin CM; Huang Z; McCaffrey DJ
    JAMA; 1994 Aug; 272(7):513; author reply 514-5. PubMed ID: 8046795
    [No Abstract]   [Full Text] [Related]  

  • 28. Niacin-induced hepatitis and thrombocytopenia after 10 years of niacin use.
    Reimund E; Ramos A
    J Clin Gastroenterol; 1994 Apr; 18(3):270-1. PubMed ID: 8034946
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of niacin therapy that simulate neoplasia: hepatic steatosis with concurrent hepatic dysfunction.
    Kristensen T; Olcott EW
    J Comput Assist Tomogr; 1999; 23(2):314-7. PubMed ID: 10096345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects of sustained-release niacin.
    Knapp TR; Middleton RK
    DICP; 1991 Mar; 25(3):253-4. PubMed ID: 2028632
    [No Abstract]   [Full Text] [Related]  

  • 31. Lactic acidosis associated with high-dose niacin therapy.
    Earthman TP; Odom L; Mullins CA
    South Med J; 1991 Apr; 84(4):496-7. PubMed ID: 2014436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Niacin-induced hepatitis].
    Gavilán JC; Bermúdez FJ; Belmonte A; González-Santos P
    Med Clin (Barc); 2002 Apr; 118(14):558. PubMed ID: 11988158
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients.
    McKenney JM; Proctor JD; Harris S; Chinchili VM
    JAMA; 1994 Mar; 271(9):672-7. PubMed ID: 8309029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute liver failure and severe cholestasis due to sulfonamides].
    Horák J; Mertl L; Hrabal P
    Cas Lek Cesk; 1985 Feb; 124(6):185-7. PubMed ID: 3871662
    [No Abstract]   [Full Text] [Related]  

  • 35. Niacin induced coagulopathy as a manifestation of occult liver injury.
    Ali EH; McJunkin B; Jubelirer S; Hood W
    W V Med J; 2013; 109(1):12-4. PubMed ID: 23413541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Niacin hepatitis.
    Patterson DJ; Dew EW; Gyorkey F; Graham DY
    South Med J; 1983 Feb; 76(2):239-41. PubMed ID: 6823602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
    McKenney J; Bays H; Koren M; Ballantyne CM; Paolini JF; Mitchel Y; Betteridge A; Kuznetsova O; Sapre A; Sisk CM; Maccubbin D
    J Clin Lipidol; 2010; 4(2):105-112.e1. PubMed ID: 21122637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regressive fulminant hepatitis, acute pancreatitis and renal insufficiency after taking ketoprofen].
    Flamenbaum M; Abergel A; Marcato N; Zénut M; Kémény JL; Cassan P
    Gastroenterol Clin Biol; 1998 Nov; 22(11):975-6. PubMed ID: 9881281
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iproniazid-prochlorperazine fulminant hepatitis (author's transl)].
    Capron JP; Gineston JL; Opolon P; Dupas JL; Denis J; Quénum C; Lorriaux A
    Gastroenterol Clin Biol; 1980 Feb; 4(2):123-7. PubMed ID: 7364170
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety profile of extended-release niacin in the AIM-HIGH trial.
    Anderson TJ; Boden WE; Desvigne-Nickens P; Fleg JL; Kashyap ML; McBride R; Probstfield JL;
    N Engl J Med; 2014 Jul; 371(3):288-90. PubMed ID: 25014706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.